Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Kees

Showing results (171-180 of 376) with videos related to

Pageof 38
Sort By:
The Journal of Clinical Endocrinology and Metabolism|January 3, 2019
Cardiometabolic Effects of Testosterone in Transmen and Estrogen Plus Cyproterone Acetate in TranswomenDaan M van Velzen, Alessia Paldino, Maartje Klaver, et al.
European Heart Journal|April 1, 2025
Low-density lipoprotein cholesterol, C-reactive protein, and lipoprotein(a) universal one-time screening in primary prevention: the EPIC-Norfolk studyJordan M Kraaijenhof, Nick S Nurmohamed, Ask T Nordestgaard, et al.
Atherosclerosis|December 6, 2022
Use of Lipoprotein(a) to improve diagnosis and management in clinical familial hypercholesterolemiaTycho R Tromp, Shirin Ibrahim, Nick S Nurmohamed, et al.
Diabetes Care|March 3, 2022
Efficacy and Safety of K-877 (Pemafibrate), a Selective PPARα Modulator, in European Patients on Statin TherapyHenry N Ginsberg, Neil J Hounslow, Yusuke Senko, et al.
Atherosclerosis|July 31, 2024
LDLR variant classification for improved cardiovascular risk prediction in familial hypercholesterolemiaShirin Ibrahim, Merel L Hartgers, Laurens F Reeskamp, et al.
Circulation|May 29, 2003
Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoproteinRadjesh J Bisoendial, G Kees Hovingh, Johannes H M Levels, et al.
Atherosclerosis|April 1, 2022
Quality of life and coping in Dutch homozygous familial hypercholesterolemia patients: A qualitative studyJanneke W C M Mulder, Leonieke W Kranenburg, Willemijn J Treling, et al.
Ebiomedicine|October 23, 2020
Differential DNA methylation in familial hypercholesterolemiaLaurens F Reeskamp, Andrea Venema, Joao P Belo Pereira, et al.
Atherosclerosis|December 20, 2014
Annexin A5 haplotypes in familial hypercholesterolemia: lack of association with carotid intima-media thickness and cardiovascular disease riskLarissa Hiddink, Geesje M Dallinga-Thie, G Kees Hovingh, et al.
The Journal of Antimicrobial Chemotherapy|June 8, 2019
Plasma and tissue pharmacokinetics of fosfomycin in morbidly obese and non-obese surgical patients: a controlled clinical trialChristoph Dorn, David Petroff, Nancy Neumann, et al.
Pageof 38

Showing results (171-180 of 376) with videos related to

Sort By:
Pageof 38
The Journal of Clinical Endocrinology and Metabolism|January 3, 2019
Cardiometabolic Effects of Testosterone in Transmen and Estrogen Plus Cyproterone Acetate in TranswomenDaan M van Velzen, Alessia Paldino, Maartje Klaver, et al.
European Heart Journal|April 1, 2025
Low-density lipoprotein cholesterol, C-reactive protein, and lipoprotein(a) universal one-time screening in primary prevention: the EPIC-Norfolk studyJordan M Kraaijenhof, Nick S Nurmohamed, Ask T Nordestgaard, et al.
Atherosclerosis|December 6, 2022
Use of Lipoprotein(a) to improve diagnosis and management in clinical familial hypercholesterolemiaTycho R Tromp, Shirin Ibrahim, Nick S Nurmohamed, et al.
Diabetes Care|March 3, 2022
Efficacy and Safety of K-877 (Pemafibrate), a Selective PPARα Modulator, in European Patients on Statin TherapyHenry N Ginsberg, Neil J Hounslow, Yusuke Senko, et al.
Atherosclerosis|July 31, 2024
LDLR variant classification for improved cardiovascular risk prediction in familial hypercholesterolemiaShirin Ibrahim, Merel L Hartgers, Laurens F Reeskamp, et al.
Circulation|May 29, 2003
Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoproteinRadjesh J Bisoendial, G Kees Hovingh, Johannes H M Levels, et al.
Atherosclerosis|April 1, 2022
Quality of life and coping in Dutch homozygous familial hypercholesterolemia patients: A qualitative studyJanneke W C M Mulder, Leonieke W Kranenburg, Willemijn J Treling, et al.
Ebiomedicine|October 23, 2020
Differential DNA methylation in familial hypercholesterolemiaLaurens F Reeskamp, Andrea Venema, Joao P Belo Pereira, et al.
Atherosclerosis|December 20, 2014
Annexin A5 haplotypes in familial hypercholesterolemia: lack of association with carotid intima-media thickness and cardiovascular disease riskLarissa Hiddink, Geesje M Dallinga-Thie, G Kees Hovingh, et al.
The Journal of Antimicrobial Chemotherapy|June 8, 2019
Plasma and tissue pharmacokinetics of fosfomycin in morbidly obese and non-obese surgical patients: a controlled clinical trialChristoph Dorn, David Petroff, Nancy Neumann, et al.
Pageof 38